RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > In Focus: Risk/Benefit and Risk Management

In Focus: Risk/Benefit and Risk Management

Posted 01 December 2009

Risk management and risk/benefit are critical concepts for the pharmaceutical and device industries. No drug or device is without risk; therefore, our focus in developing and marketing these products should be to understand the risks versus benefits for specific patient populations. In other words, for which patient populations do the potential benefits outweigh the risks? In some cases, this is a decision best made by the patient and physician.


© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.